
Pglit 15mg Tablet
Marketer
Chemech Laboratories Ltd
Salt Composition
Pioglitazone (15mg)
Overview Pglit 15mg Tablet
Glimfast 15mg tablets are indicated for adult patients with type 2 diabetes. This medication assists in managing blood glucose levels, thereby mitigating the risk of severe diabetic complications such as vision impairment and nephropathy. Glimfast 15mg may be administered alone or in conjunction with other therapies, with or without food, consistently at the same time daily for optimal efficacy. Dosage adjustments, determined by your physician, may occur based on treatment response. Continued use, even with controlled blood sugar or well-being, is crucial. Discontinuing treatment without medical consultation can lead to elevated blood glucose, increasing the risk of kidney disease, blindness, neuropathy, and limb loss. Remember, this medication is a component of a comprehensive diabetes management plan that also includes dietary modifications, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common adverse effects include headache, sinusitis, myalgia, and pharyngitis. Report any persistent or bothersome side effects to your physician. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to commencing treatment, inform your physician of any history of heart disease, thyroid disorders, or endocrine conditions, as it may not be appropriate. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Pglit 15mg Tablet
Managing type 2 diabetes
Major Benefits of Pglit 15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 15mg Pglit tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Pglit 15mg Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Pglit 15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The 15mg Pglit tablet can be consumed with or without food, although consistent timing is recommended.
How Pglit 15mg Tablet works:
Glimepiride 15mg tablets are used to manage diabetes. Their action involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pglit 15mg Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Pglit 15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Use of the Pglit 15mg Tablet during breastfeeding requires careful consideration. Lactation should be temporarily suspended until maternal treatment concludes and the medication is fully cleared from the mother's system. Close monitoring of the infant's blood glucose levels is necessary while the mother is taking Pglit 15mg Tablets.
DrivingSAFE
Driving ability is typically unaffected by Pglit 15mg Tablet.
KidneySAFE IF PRESCRIBED
Pglit 15mg tablets pose no safety concerns for patients with kidney impairment; no dosage modification is necessary.
LiverCAUTION
Individuals with liver impairment should use Pglit 15mg Tablets cautiously, potentially requiring a modified dosage. Medical advice is essential. Pglit 15mg Tablets are contraindicated for patients exhibiting severe hepatic dysfunction.
What if you forget to take Pglit 15mg Tablet :
Omit any missed Pglit 15mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Pglit 15mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Thiazolidinedione compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | PPAR-gamma agonist (thiazolidinedione) |
